Background: The environment, including farms, might act as a reservoir for mobile colistin resistance (mcr) genes, which has led to calls for reduction of usage in livestock of colistin, an antibiotic of last resort for humans. Objectives: To establish the molecular epidemiology of mcr Enterobacteriaceae from faeces of two cohorts of pigs, where one group had initially been treated with colistin and the other not, over a 5 month period following stoppage of colistin usage on a farm in Great Britain; faecal samples were also taken at ∼20 months. Methods: mcr-1 Enterobacteriaceae were isolated from positive faeces and was WGS performed; conjugation was performed on selected Escherichia coli and colistin MICs were determined. Results: E. coli of diverse ST harbouring mcr-1 and multiple resistance genes were isolated over 5 months from both cohorts. Two STs, from treated cohorts, contained both mcr-1 and mcr-3 plasmids, with some isolates also harbouring multiple copies of mcr-1 on different plasmids. The mcr-1 plasmids grouped into four Inc types (X4, pO111, I2 and HI2), with mcr-3 found in IncP. Multiple copies of mcr plasmids did not have a noticeable effect on colistin MIC, but they could be transferred simultaneously to a Salmonella host in vitro. Neither mcr-1 nor mcr-3 was detected in samples collected ∼20 months after colistin cessation. Conclusions: We report for the first known time on the presence in Great Britain of mcr-3 from MDR Enterobacteriaceae, which might concurrently harbour multiple copies of mcr-1 on different plasmids. However, control measures, including stoppage of colistin, can successfully mitigate long-term on-farm persistence.
Background: The environment, including farms, might act as a reservoir for mobile colistin resistance (mcr) genes, which has led to calls for reduction of usage in livestock of colistin, an antibiotic of last resort for humans. Objectives: To establish the molecular epidemiology of mcr Enterobacteriaceae from faeces of two cohorts of pigs, where one group had initially been treated with colistin and the other not, over a 5 month period following stoppage of colistin usage on a farm in Great Britain; faecal samples were also taken at ∼20 months. Methods: mcr-1 Enterobacteriaceae were isolated from positive faeces and was WGS performed; conjugation was performed on selected Escherichia coli and colistin MICs were determined. Results:E. coli of diverse ST harbouring mcr-1 and multiple resistance genes were isolated over 5 months from both cohorts. Two STs, from treated cohorts, contained both mcr-1 and mcr-3 plasmids, with some isolates also harbouring multiple copies of mcr-1 on different plasmids. The mcr-1 plasmids grouped into four Inc types (X4, pO111, I2 and HI2), with mcr-3 found in IncP. Multiple copies of mcr plasmids did not have a noticeable effect on colistin MIC, but they could be transferred simultaneously to a Salmonella host in vitro. Neither mcr-1 nor mcr-3 was detected in samples collected ∼20 months after colistin cessation. Conclusions: We report for the first known time on the presence in Great Britain of mcr-3 from MDR Enterobacteriaceae, which might concurrently harbour multiple copies of mcr-1 on different plasmids. However, control measures, including stoppage of colistin, can successfully mitigate long-term on-farm persistence.
Authors: Manal AbuOun; Heather M O'Connor; Emma J Stubberfield; Javier Nunez-Garcia; Ellie Sayers; Derick W Crook; Richard P Smith; Muna F Anjum Journal: Front Microbiol Date: 2020-05-25 Impact factor: 5.640
Authors: Lourdes Migura-Garcia; Juan J González-López; Jaime Martinez-Urtaza; J R Aguirre Sánchez; A Moreno-Mingorance; A Perez de Rozas; Ursula Höfle; Y Ramiro; Narjol Gonzalez-Escalona Journal: Front Microbiol Date: 2020-01-17 Impact factor: 5.640
Authors: Liam P Shaw; Kevin K Chau; James Kavanagh; Manal AbuOun; Emma Stubberfield; H Soon Gweon; Leanne Barker; Gillian Rodger; Mike J Bowes; Alasdair T M Hubbard; Hayleah Pickford; Jeremy Swann; Daniel Gilson; Richard P Smith; Sarah J Hoosdally; Robert Sebra; Howard Brett; Tim E A Peto; Mark J Bailey; Derrick W Crook; Daniel S Read; Muna F Anjum; A Sarah Walker; Nicole Stoesser Journal: Sci Adv Date: 2021-04-09 Impact factor: 14.136
Authors: Natalie Effelsberg; Iris Kobusch; Sabrina Linnemann; Franka Hofmann; Hannah Schollenbruch; Alexander Mellmann; Marc Boelhauve; Robin Köck; Christiane Cuny Journal: One Health Date: 2021-11-27
Authors: Nathaniel Storey; Shaun Cawthraw; Olivia Turner; Margherita Rambaldi; Fabrizio Lemma; Robert Horton; Luke Randall; Nicholas A Duggett; Manal AbuOun; Francesca Martelli; Muna F Anjum Journal: Microb Genom Date: 2022-03
Authors: Carlos Bastidas-Caldes; Jacobus H de Waard; María Soledad Salgado; María José Villacís; Marco Coral-Almeida; Yoshimasa Yamamoto; Manuel Calvopiña Journal: Pathogens Date: 2022-06-08
Authors: Valeria Bortolaia; Rolf S Kaas; Etienne Ruppe; Marilyn C Roberts; Stefan Schwarz; Vincent Cattoir; Alain Philippon; Rosa L Allesoe; Ana Rita Rebelo; Alfred Ferrer Florensa; Linda Fagelhauer; Trinad Chakraborty; Bernd Neumann; Guido Werner; Jennifer K Bender; Kerstin Stingl; Minh Nguyen; Jasmine Coppens; Basil Britto Xavier; Surbhi Malhotra-Kumar; Henrik Westh; Mette Pinholt; Muna F Anjum; Nicholas A Duggett; Isabelle Kempf; Suvi Nykäsenoja; Satu Olkkola; Kinga Wieczorek; Ana Amaro; Lurdes Clemente; Joël Mossong; Serge Losch; Catherine Ragimbeau; Ole Lund; Frank M Aarestrup Journal: J Antimicrob Chemother Date: 2020-12-01 Impact factor: 5.790